CN Patent

CN1671385A — 含有瑞帕霉素羟基酯的胃肠外制剂

Assigned to Wyeth LLC · Expires 2005-09-21 · 21y expired

What this patent protects

本发明提供了3－羟基－2－(羟基甲基)－2－甲基丙酸的瑞帕霉素42－酯(CCI－779)的胃肠外制剂。

USPTO Abstract

本发明提供了3－羟基－2－(羟基甲基)－2－甲基丙酸的瑞帕霉素42－酯(CCI－779)的胃肠外制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN1671385A
Jurisdiction
CN
Classification
—
Expires
2005-09-21
Drug substance claim
No
Drug product claim
No
Assignee
Wyeth LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.